Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials

Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351).
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. NEJM Study Shows Supplements Relieve Mild Forms of Arthritis NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain. NEJM Study Shows Supplements Relieve Mild Forms of Arthritis NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain. NEJM Study Shows Supplements Relieve Mild Forms of Arthritis NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain. New Study To Evaluate Celadrin Capsules For Patients With Knee Pain Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain New Study To Evaluate Celadrin Capsules For Patients With Knee Pain Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain New Study To Evaluate Celadrin Capsules For Patients With Knee Pain Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Clinical Trial: Gene therapy research switches off joint inflammation; switches on genetic process of joint repair Scientists at Case Western Reserve University School of Medicine and Albany Medical College, together with Rainforest Nutritionals, Inc. have demonstrated in a mini symposium held today at the 14th International Conference of the Inflammation Research Association (IRA) that a blend of natural botanical products called Reparagen have turned on the master repair gene, IGF-1, which is responsible for growing human cartilage and restores joint function while blocking joint destruction associated with inflammation. Multi-center, Randomized controlled Clinical Trial Underway. Clinical Trial: Gene therapy research switches off joint inflammation; switches on genetic process of joint repair Scientists at Case Western Reserve University School of Medicine and Albany Medical College, together with Rainforest Nutritionals, Inc. have demonstrated in a mini symposium held today at the 14th International Conference of the Inflammation Research Association (IRA) that a blend of natural botanical products called Reparagen have turned on the master repair gene, IGF-1, which is responsible for growing human cartilage and restores joint function while blocking joint destruction associated with inflammation. Multi-center, Randomized controlled Clinical Trial Underway. Turmeric supplements show promise in treating arthritis New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response. Turmeric supplements show promise in treating arthritis New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response. Turmeric supplements show promise in treating arthritis New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response. Turmeric supplements show promise in treating arthritis New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response. Turmeric supplements show promise in treating arthritis New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response. Turmeric supplements show promise in treating arthritis New study published in the November 2006 issue of Arthritis & Rheumatism examines the effect and mechanism of turmeric on arthritis, shows that a version free of essential oils prevented acute and chronic arthritis, even when it was administered after arthritis had been induced, as well as inhibited a protein that controls the gene expression of substances that produce an inflammatory response. New In-Vitro Study Finds Hyal-Joint(TM) Nourishes Synovial Fluid During the study, a culture of human osteoarthritic synoviocytes were stimulated using either Hyal-Joint(TM), with researchers observing that after the 12 and 24 hour¹ incubation periods, the cell culture stimulated using Hyal-Joint(TM) demonstrated significantly higher values of endogenous HA than the cell culture stimulated by HA from bacterial fermentation. New In-Vitro Study Finds Hyal-Joint(TM) Nourishes Synovial Fluid During the study, a culture of human osteoarthritic synoviocytes were stimulated using either Hyal-Joint(TM), with researchers observing that after the 12 and 24 hour¹ incubation periods, the cell culture stimulated using Hyal-Joint(TM) demonstrated significantly higher values of endogenous HA than the cell culture stimulated by HA from bacterial fermentation. New In-Vitro Study Finds Hyal-Joint(TM) Nourishes Synovial Fluid During the study, a culture of human osteoarthritic synoviocytes were stimulated using either Hyal-Joint(TM), with researchers observing that after the 12 and 24 hour¹ incubation periods, the cell culture stimulated using Hyal-Joint(TM) demonstrated significantly higher values of endogenous HA than the cell culture stimulated by HA from bacterial fermentation. WOKVEL® Extract found effective in comparative human study for joint health Study, published in the February 2007 issue of the Indian Journal of Pharmacology found a sustained decrease in WOMAC score for WOKVEL Extract and valdecoxib, a non-steroidal anti-inflammatory drug (NSAID) over a seven month period. WOKVEL® Extract found effective in comparative human study for joint health Study, published in the February 2007 issue of the Indian Journal of Pharmacology found a sustained decrease in WOMAC score for WOKVEL Extract and valdecoxib, a non-steroidal anti-inflammatory drug (NSAID) over a seven month period. WOKVEL® Extract found effective in comparative human study for joint health Study, published in the February 2007 issue of the Indian Journal of Pharmacology found a sustained decrease in WOMAC score for WOKVEL Extract and valdecoxib, a non-steroidal anti-inflammatory drug (NSAID) over a seven month period. New Study Finds Celadrin® Significantly Improves Knee Function and Joint Mobility Research study conducted with Celadrin® shows that after eight weeks of capsule consumption, average walking ability increased 45 percent, and participants claimed a 35 percent decrease in knee discomfort. New Study Finds Celadrin® Significantly Improves Knee Function and Joint Mobility Research study conducted with Celadrin® shows that after eight weeks of capsule consumption, average walking ability increased 45 percent, and participants claimed a 35 percent decrease in knee discomfort. New Study Finds Celadrin® Significantly Improves Knee Function and Joint Mobility Research study conducted with Celadrin® shows that after eight weeks of capsule consumption, average walking ability increased 45 percent, and participants claimed a 35 percent decrease in knee discomfort. Study confirms “MSM provides moderate evidence of efficacy for knee OA” The journal Arthritis Research & Therapy reviewed 2,026 OA nutritional supplement studies and concludes that only three supplements including MSM are supported by good to moderate evidence. Study confirms “MSM provides moderate evidence of efficacy for knee OA” The journal Arthritis Research & Therapy reviewed 2,026 OA nutritional supplement studies and concludes that only three supplements including MSM are supported by good to moderate evidence. Study confirms “MSM provides moderate evidence of efficacy for knee OA” The journal Arthritis Research & Therapy reviewed 2,026 OA nutritional supplement studies and concludes that only three supplements including MSM are supported by good to moderate evidence. INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) HHS: Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee A new scientific review released today by the Department of Health & Human Services's (HHS) Agency for Healthcare Research and Quality (AHRQ) concludes that evidence of benefit is lacking for many common ways of treating osteoarthritis of the knee, including popular dietary supplement ingredients. HHS: Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee A new scientific review released today by the Department of Health & Human Services's (HHS) Agency for Healthcare Research and Quality (AHRQ) concludes that evidence of benefit is lacking for many common ways of treating osteoarthritis of the knee, including popular dietary supplement ingredients. HHS: Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee A new scientific review released today by the Department of Health & Human Services's (HHS) Agency for Healthcare Research and Quality (AHRQ) concludes that evidence of benefit is lacking for many common ways of treating osteoarthritis of the knee, including popular dietary supplement ingredients. Advances In the Treatment Of Synovitis New information and additional research will be the subject of an educational symposium following the Annual Scientific Meeting of the American College of Rheumatology (ACR). The half-day symposium entitled “Osteoarthritis and Synovitis: The Link Between Pathogenesis, Detection and Treatment,” will be held Sunday, November 11, 2007 at the Westin Boston Waterfront Hotel in Boston, MA. Advances In the Treatment Of Synovitis New information and additional research will be the subject of an educational symposium following the Annual Scientific Meeting of the American College of Rheumatology (ACR). The half-day symposium entitled “Osteoarthritis and Synovitis: The Link Between Pathogenesis, Detection and Treatment,” will be held Sunday, November 11, 2007 at the Westin Boston Waterfront Hotel in Boston, MA. Advances In the Treatment Of Synovitis New information and additional research will be the subject of an educational symposium following the Annual Scientific Meeting of the American College of Rheumatology (ACR). The half-day symposium entitled “Osteoarthritis and Synovitis: The Link Between Pathogenesis, Detection and Treatment,” will be held Sunday, November 11, 2007 at the Westin Boston Waterfront Hotel in Boston, MA. Study Shows Pine Bark Improved Physical Function A double-blind, placebo-controlled study published in the journal Nutrition Research reveals Pycnogenol(R), an antioxidant plant extract from the bark of the French maritime pine tree, improved physical function by 52 percent in patients suffering from OA. Study Shows Pine Bark Improved Physical Function A double-blind, placebo-controlled study published in the journal Nutrition Research reveals Pycnogenol(R), an antioxidant plant extract from the bark of the French maritime pine tree, improved physical function by 52 percent in patients suffering from OA. Study Shows Pine Bark Improved Physical Function A double-blind, placebo-controlled study published in the journal Nutrition Research reveals Pycnogenol(R), an antioxidant plant extract from the bark of the French maritime pine tree, improved physical function by 52 percent in patients suffering from OA. Findings Presented at the OsteoArthritis Research Society Researchers from the University of California, San Diego presented new research findings yesterday at the 2007 World Congress on Osteoarthritis in Ft. Lauderdale, providing the first evidence of how methylsulfonylmethane (MSM) may protect articular cartilage and reduce inflammation in osteoarthritis. The form of MSM used in the study, OptiMSM was provided by Bergstrom Nutrition. Findings Presented at the OsteoArthritis Research Society Researchers from the University of California, San Diego presented new research findings yesterday at the 2007 World Congress on Osteoarthritis in Ft. Lauderdale, providing the first evidence of how methylsulfonylmethane (MSM) may protect articular cartilage and reduce inflammation in osteoarthritis. The form of MSM used in the study, OptiMSM was provided by Bergstrom Nutrition. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Raleigh, NC. – Reparagen(TM), a breakthrough in managing arthritis and joint damage which in lab tests was shown to activate a critical repair gene, IGF-1 in human cartilage while blocking joint destruction associated with inflammation, has now entered clinical trials. The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC (www.santerra-pharma.com) was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351). Both Santerra and Rainforest Nutritionals believe in the importance of exemplary science performed in open access manner and details of this 8 week clinical study in 80 subjects can be found at http://www.controlled-trials.com/ISRCTN25438351. Mark J.S. Miller, Ph.D., M.B.A., Professor of Cardiovascular Sciences and Pediatrics at Albany Medical College (NY) and head of the Scientific Advisory Board said that, “This trial is important because it directly compares Reparagen with glucosamine in treating subjects with moderate osteoarthritis. Glucosamine is both familiar to consumers and is currently a gold standard in the natural product approach to osteoarthritis although recent studies have described its limitations and the need for effective alternatives.” The clinical trial will compare Reparagen versus glucosamine in a variety of pain, mobility and functional assessments in subjects with moderate osteoarthritis of the knee. Prior to this clinical investigation Reparagen was found to be the first natural product to “silence” genes that promote joint damage while simultaneously activating the repair gene, IGF-1, in human chondrocytes. This research was published in the open access journal BMC Complementary & Alternative Medicine (http://www.biomedcentral.com/1472-6882/6/13). Rainforest Nutritionals, Inc. Vice President Paul Bobrowski emphasized that, “Reparagen continues to set a new standard in the joint health market, emphasized by this clinical study and the Current Controlled Trials validation.” Elaborating Bobrowski said, “We believe that Reparagen’s unique action and its NIH innovation Award makes it the alternative to glucosamine or chondroitin that consumers are seeking”. About Rainforest Nutritionals, Inc Founded in 2002, Rainforest Nutritionals, Inc. (www.rainforest-inc.com) is dedicated to the development of innovative natural therapeutics for the business to business market. About Santerra Pharmaceuticals, LLC Santerra Pharmaceuticals, LLC is a contract research organization that specializes in scientific and clinical support for companies active in the natural products sector. For further information visit www.reparagen.com or call 1-866-795-7246.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software